Julie L. Gerberding - EVP, Chief Patient Officer at Merck & Co., Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Patient Officer
Stock Symbol
MRK on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julie L. Gerberding since 11/5/2023

Holdings reported by Julie L. Gerberding for Merck & Co., Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48.7K $5.82M $119.43 Feb 24, 2022 Direct

Transactions reported by Julie L. Gerberding for Merck & Co., Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.